Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Covidien Recalls Mislabeled Insulin Syringes - Medical Product Outsourcing

Covidien Recalls Mislabeled Insulin Syringes

Recall prompted by possible mislabeling

Covidien is recalling one lot of ReliOn sterile, single-use, disposable, hypodermic syringes with permanently affixed hypodermic needles due to possible mislabeling.

Using these syringes may cause patients to take more than twice the intended dose, which may lead to serious health consequences or death, according to an FDA statement.

The 471,000 syringes, labeled U-40 insulin and U-100 insulin, may have been mixed in boxes during packaging. They were sold at Walmart and Sam’s Clubs stores between Aug. 1 and Oct. 8.

SOURCE: FDA NEWS

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters